NEVVI Medicare utilization intelligence
+ Build a code basket
Market snapshot

Nationwide CY2024

Medicare Part B FFS · CY2024 · as published by CMS
G6014 Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 20 mev or greater HCPCS · Radiation Oncology treatment
Classification Treatment Radiation Oncology Conventional Radiation Treatment (CMS RBCS)
First observed 2015
National scale 3,272 services ▼ 36.7% YoY · 458 beneficiaries (CY2024, Medicare FFS)
Medicare paid $591K · $180.70 avg / service, national
CMS descriptor · RBCS classification · Medicare Part B physician/supplier claims, 12-year window
Billing groups
7
Named-group FFS services
1,346
FFS of Medicare
49%
Services YoY
-36.7%
FFS enrollment -2.2%
Estimated all-Medicare volume FFS + estimated MA estimate
~2,760 services

1,346 observed fee-for-service (49%) · ~1,414 estimated Medicare Advantage. Scaled from the observed floor by each state’s fee-for-service share (FFS share as of 2024) — scaled estimate — assumes MA utilization mirrors FFS; not an observation. How we scale

Top states — G6014 (CY2024)

Disclosed Medicare fee-for-service services by billing state; open a bar for that state's ranked market.

Named-group submitted charges
$937K
Named-group allowed amount
$322K
Named-group Medicare payments
$258K
Avg charge / svc
$696
Avg allowed / svc
$240
Avg payment / svc
$191
Average charge per group
$390 7 groups · avg submitted charge / service $1,108
Market analyticsPlatform
a taste of the twelve-year trend layer

Or just look at it: nuclear heart imaging (78452) in Arizona is open as a live example — the full paid view, real data.

View the live example →

Nevvi's market analytics platform — code baskets, market structure and share, the twelve-year trend layer — is built and not launched yet. We're gathering interest in it.

Notify me at launch →
Refine: practice size any 5+ 25+ 100+ independent only
Filter results:

Email me this CSV

Data year: CY2024 CY2023 CY2022 locked column CY2021 locked column CY2020 locked column
Physician groups ranked by G6014 services, highest first, CY2024
# Physician group activate to sort City activate to sort St activate to sort Specialty activate to sort Providers activate to sort G6014 svcs sorted descending — activate to reverse Submitted charges activate to sort Avg charge activate to sort Medicare $ locked column Share* activate to sort Phone
1 NORMAN H. ANDERSON, MD, PA OCALA FL RADIATION ONCOLOGY 10 381 $200,312 $526 premium 38.8% (352) 732-0277
2 REGIONAL CANCER CARE ASSOCIATES LLC HACKENSACK NJ HEMATOLOGY/ONCOLOGY 153 347 $214,099 $617 premium 100.0% (201) 996-2210
3 SUTTER BAY MEDICAL FOUNDATION PALO ALTO CA INTERNAL MEDICINE 3716 149 $165,092 $1,108 premium 100.0% (415) 600-1020
4 FAYETTE ONCOLOGY ASSOCIATES UNIONTOWN PA RADIATION ONCOLOGY 5 148 $125,356 $847 premium 30.2% (724) 437-2503
5 UPMC/CONEMAUGH CANCER CENTER JOHNSTOWN PA RADIATION ONCOLOGY 4 132 $111,804 $847 premium 26.9% (814) 534-4724
6 MOUNTAIN VIEW CANCER ASSOCIATES GREENSBURG PA RADIATION ONCOLOGY 3 101 $85,547 $847 premium 20.6% (724) 838-1900
7 CANCER NETWORK OF WEST CENTRAL OHIO CELINA OH RADIATION ONCOLOGY 3 88 $34,320 $390 premium 48.4% (419) 584-1900

*Share of the state's disclosed Medicare-FFS services for the primary code, counted once per clinician. "St" is the state the volume was billed from: a group appears in each state where its clinicians bill Medicare, with that state's volume and share ("City" is the group's registered location). Group figures sum clinicians affiliated with exactly one group; clinicians in several groups are listed in each group's drill-down but not volume-attributed to any single group, so shares reflect attributable volume. See Methods.

Comparing against an all-payer estimate?

These are exact counts from Medicare fee-for-service claims — roughly a third to half of most procedure markets, depending on payer mix. Modeled all-payer databases project the remainder statistically; we publish the audited floor and label it as such. Same market, different denominator. How the numbers reconcile →